Apheresis as Therapy

Aferetica is an Innovative Small and Medium-sized Enterprise (SME), founded by Managers with tens of years of experience in Dialysis, Intensive Care, Cardiology and Medical Devices.

The company proposes itself as a catalyst for the creation of a Network of Clinicians, Academics, Researchers and Institutions, to create and validate New Apheretic Therapies, even for unexplored clinical areas.

An integrated and innovative vision of apheretic therapies is the challenge to face for a real evolution of the cure.

EVENTS

APHERESIS

Contribute to research for the development, creation and diffusion of complete apheretic therapies.

MORE

TRANSPLANTATION

For a concrete breakthrough in organ availability and transplantation outcome.

MORE

CRITICAL CARE

Apheresis as therapy: new frontiers in critically ill patients.

MORE

Our Therapeutic Systems

Products, knowledges, therapeutic protocols and clinical research.

PerLife tm
kawasumi
PerLungs
Plasmapher Apherlung
Cardiosmart
Cytosorb
Leucapher
HF440
abioSCOPE
https://www.aferetica.com/en/therapeutical-solutions/aphercap/

Last updates

  • Registro CytoSorb<sup>®</sup>

CytoSorb® Registry

CytoSorb® Registry is an independent international registry coordinated by the University Hospital of Jena and aimed at collecting data of all patients treated with CytoSorb®.